Violation Tracker Parent Company Summary
Top 5 Offense Groups (Groups Defined) | Penalty Total | Number of Records |
---|---|---|
healthcare-related offenses | $534,500,000 | 3 |
competition-related offenses | $500,116,200 | 7 |
government-contracting-related offenses | $320,338,719 | 5 |
financial offenses | $150,006,600 | 2 |
employment-related offenses | $41,380,203 | 2 |
Top 5 Primary Offense Types | Penalty Total | Number of Records |
---|---|---|
off-label or unapproved promotion of medical products | $534,500,000 | 3 |
False Claims Act and related | $320,338,719 | 5 |
fraud | $300,000,000 | 1 |
price-fixing or anti-competitive practices | $156,100,000 | 3 |
accounting fraud or deficiencies | $150,000,000 | 1 |
Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.
American Pharmaceutical Partners, Inc.; BRISTOL MYERS SQUIBB; BRISTOL MYERS SQUIBB MEDICAL IMAGING; BRISTOL MYERS SQUIBB MFG; Bristol-Myers Squibb Company and Apothecon, Inc.; Briston-Myers Squibb; CELGENE; DUPONT PHARMACEUTICALS; ER SQUIBB AND SONS; Global Strategic Partners LLC
Individual Penalty Records:
Click on the company or penalty amount for more information on each case.Company | Primary Offense Type | Year | Agency |
Penalty Amount![]() |
---|---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | environmental violation | 2000 | EPA | $5,000 |
E.R. SQUIBB & SONS, LLC. | environmental violation | 2013 | EPA | $5,950 |
Celgene Corporation | environmental violation | 2013 | EPA | $6,035 |
DuPont Pharmaceuticals Company | economic sanction violation | 2004 | OFAC | $6,600 |
BRISTOL-MYERS SQUIBB CO | environmental violation | 2001 | EPA | $7,600 |
E.R. Squibb & Sons LLC | environmental violation | 2009 | EPA | $8,125 |
Global Strategic Partners LLC | motor vehicle safety violation | 2015 | FMCSA | $8,680 |
Bristol-Myers Squibb Medical Imaging, Inc. | export control violation | 2004 | BIS | $16,200 |
BRISTOL - MYERS SQUIBB MEDICAL IMAGING INC | environmental violation | 2009 | EPA | $19,538 |
BRISTOL-MYERS SQUIBB CO | environmental violation | 2011 | EPA | $20,000 |
Bristol Myers Squibb Manufacturing Company | environmental violation | 2008 | EPA | $52,000 |
Bristol Myers Squibb Company | environmental violation | 2008 | EPA | $66,770 |
American Pharmaceutical Partners, Inc. | wage and hour violation | 2004 | WHD | $160,203 |
Bristol-Myers Squibb | drug or medical equipment safety violation | 2007 | DOJ_ANTITRUST | $1,000,000 |
Bristol-Myers Squibb Company | price-fixing or anti-competitive practices | 2008 | MULTI-AG | $1,100,000 |
Bristol-Myers Squibb Company | consumer protection violation | 2019 | WV-AG | $1,600,000 |
Bristol-Myers Squibb Company and Apothecon, Inc. | False Claims Act and related | 2008 | ID-AG | $1,738,719 |
Bristol-Myers Squibb Company | consumer protection violation | 2009 | FTC | $2,100,000 |
Bristol-Myers Squibb | environmental violation | 2009 | EPA | (*) $2,328,154 |
Bristol-Myers Squibb | environmental violation | 2008 | EPA | $3,650,000 |
Bristol-Myers Squibb | False Claims Act and related | 2008 | AL-AG | $11,000,000 |
Bristol-Myers Squibb | Foreign Corrupt Practices Act | 2015 | SEC | $14,000,000 |
Bristol-Myers Squibb | off-label or unapproved promotion of medical products | 2016 | MULTI-AG | $19,500,000 |
Celgene Corp. | off-label or unapproved promotion of medical products | 2017 | MULTI-AG | (*) $20,700,000 |
Bristol-Myers Squibb | False Claims Act and related | 2010 | PA-AG | $27,600,000 |
Bristol-Myers Squibb | kickbacks and bribery | 2016 | CA-INS | $30,000,000 |
Briston-Myers Squibb | benefit plan administrator violation | 2005 | private lawsuit-federal | $41,220,000 |
Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $55,000,000 |
Bristol-Myers Squibb Co. | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $100,000,000 |
Bristol-Myers Squibb Company | accounting fraud or deficiencies | 2004 | SEC | $150,000,000 |
Bristol-Myers Squibb | False Claims Act and related | 2008 | MULTI-AG | (*) $187,000,000 |
Celgene Corp. | False Claims Act and related | 2017 | USAO | $280,000,000 |
Bristol-Myers Squibb | fraud | 2005 | USAO | $300,000,000 |
Bristol-Myers Squibb Company | off-label or unapproved promotion of medical products | 2007 | DOJ_CIVIL | $515,000,000 |